Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias

Details for Australian Patent Application No. 2005254924 (hide)

Owner AstraZeneca AB

Inventors Bonn, Peter; Ponten, Fritiof; Olsson, Christina; Kajanus, Johan; Gran, Ulrik; Bjore, Annika

Agent Davies Collison Cave

Pub. Number AU-B-2005254924

PCT Pub. Number WO2005/123748

Priority 0401539-2 15.06.04 SE

Filing date 13 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 27 August 2009

International Classifications

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123748 Priority application(s): WO2005/123748

27 August 2009 Application Accepted

  Published as AU-B-2005254924

24 December 2009 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254927-A device for mechanical guiding, a lock module and a lock device comprising such a device

2005254923-Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias